Advertising and Marketing
Novo Nordisk Sales Rep Loses Retaliation Lawsuit more
Three Strikes and They're Out? moreZyprexa Document Leaker Loses His Appeal moreThe FDA Probes Glaxo Over Avandia Disclosures more |
Pharma Watch
Now The States Are Going After Johnson & Johnson moreFormer Sirtris Execs' Nonprofit Starts Selling Resveratrol with Potential Anti-Aging Effects Online more Another Twist in the Chronicles of Avandia! moreAn Embarassed Glaxo Spanks Two Key Executives moreU.S. Broadens Bribery Inquiry Into Drug Makers moreAgencies Probe Merck For Foreign Anti-Bribery Law Violations moreWHO Identifies Conflicted Pandemic Panel Members more |
PBM Watch
CVS Caremark: Testing Nudges to Improve Medication Compliance moreDrug Managers Medco, CVS Giving Gene Tests to Millions in U.S. morePrices Drop For PBMs; Pharmacy Lobby Opposes Survey Regarding Medicaid Prices morePBM Medco Invests In Comparative-Effectiveness, Safety Research Firm more |
Pharmaceutical Pricing and Reimbursement
Bristol-Myers & ADAPs Near Deal On AIDS Meds morePharmaceutical Policies: Effects of Restrictions on Reimbursement more |
Patents and Generics
Big-Time Savings on Rx Drugs: Is the End of Pay-for-Delay in Sight? moreCan Eli Lilly Win Any Important Patent Lawsuit? moreRoche Hit With New Breed of Patent Suit more |
Medicare and Medicaid
Antibiotic Use Up After Part D moreHouse Approves State Aid Package, Including $16 Billion In Federal Medicaid Assistance moreMore Medicare Part D Checks In The Mail moreStates Consider How Best To Spend Extra Medicaid Funds moreObama Signs Bill Giving States $16 Billion In Enhanced Medicaid Payments moreCMS: Seniors Will See Modest Increase In Medicare Drug Premiums But Improved Benefits moreSebelius To Governors: Extra Medicaid Money Comes With A String Attached moreLawmakers Want Medicare Ad Pulled more |
Safety and Clinical Trials
FDA Panel Rejects Jazz Drug as Pain-Disorder Treatment moreLilly Drops 'Major Hope' Alzheimer's Drug | >> moreAvastin shouldn't make the FDA give up on 'accelerated approval' of drugs moreFDA Considers Dropping Avastin Approval, Approves Five-Day Emergency Contraception Pill moreGenentech, Biogen And A 'Flaccid' Quadriplegic moreU.S. FDA panel backs Glaxo, Valeant epilepsy drug moreEuropean Agency Agrees To Release Side Effect Data moreGilead Facility May Get FDA Warning Letter more |
Conflict of Interest, CME, and Academic Detailing
Separate Doctors From Industry moreUniversity of Minnesota Defends Conflicts Policy more |
Subscribe to the NLARx Blog and Join us on Facebook!
For up-to-the-minute posting of news of interest and events,
become a fan of NLARx on Facebook here and subscribe to our Blog.
|
